Co-Authors
This is a "connection" page, showing publications co-authored by Kyong Peck and Eun-Jeong Joo.
Connection Strength
1.846
-
Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study. J Korean Med Sci. 2021 Mar 22; 36(11):e83.
Score: 0.936
-
Evaluation of six anti-SARS-CoV-2 antibody test kits and practical approaches to optimize the diagnostic performance. J Microbiol Immunol Infect. 2021 Oct; 54(5):983-986.
Score: 0.234
-
Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients. J Clin Med. 2020 Jul 17; 9(7).
Score: 0.223
-
Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care. J Microbiol Immunol Infect. 2021 Feb; 54(1):97-100.
Score: 0.223
-
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19. Infect Chemother. 2021 Jun; 53(2):395-403.
Score: 0.059
-
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19. Infect Chemother. 2021 Mar; 53(1):166-219.
Score: 0.058
-
PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19. Immunity. 2021 01 12; 54(1):44-52.e3.
Score: 0.057
-
Interim Guidelines on Antiviral Therapy for COVID-19. Infect Chemother. 2020 Jun; 52(2):281-304.
Score: 0.055